Skip to main content
Erschienen in: World Journal of Surgery 7/2008

01.07.2008

Prevalence and Prognostic Significance of Poor Differentiation and Tall Cell Variant in Papillary Carcinoma in Japan

verfasst von: Yasuhiro Ito, Mitsuyoshi Hirokawa, Mitsuhiro Fukushima, Hiroyuki Inoue, Tomonori Yabuta, Takashi Uruno, Minoru Kihara, Takuya Higashiyama, Yuuki Takamura, Akihiro Miya, Kaoru Kobayashi, Fumio Matsuzuka, Akira Miyauchi

Erschienen in: World Journal of Surgery | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

In the 1980s, histology of a poorly differentiated carcinoma showing an aggressive behavior was proposed by Sakamoto et al. and other pathologists. This was adopted as an independent entity by the World Health Organization (WHO) and in the General Rules for the Description of Thyroid Cancer by The Japanese Society of Thyroid Surgery (JSTS). Furthermore, the Turin classification was recently proposed as the newest classification system for poorly differentiated carcinoma. Furthermore, although tall cell variant is not included in poorly differentiated carcinoma, it is thought to show aggressive characteristics. In this study, we investigated the prevalence and clinical significance of three types of poorly differentiated carcinoma defined by the WHO classification system (poorly differentiated carcinoma [WHO]), Turin proposal (poorly differentiated carcinoma [Turin]), and JSTS (poorly differentiated carcinoma [Sakamoto]), and tall cell variant in papillary carcinoma.

Methods

We investigated the prevalence and prognostic significance of these three histological types in 1707 papillary carcinomas.

Results

In our series, 189 (11.1%), 15 (0.8%), 5 (0.3%), and 62 (3.6%) patients were diagnosed as having poorly differentiated carcinoma (Sakamoto), poorly differentiated carcinoma (WHO), poorly differentiated carcinoma (Turin), and tall cell variant, respectively. Poorly differentiated carcinoma (WHO) and tall cell variant independently affected cause-specific survival (CSS) of patients, but poorly differentiated carcinoma (Sakamoto) predicted only worse disease-free survival (DFS) of patients on multivariate analysis. Poorly differentiated carcinoma (Turin) showed the worst DFS and CSS rates of patients but was not confirmed as an independent prognostic factor probably because of the small number of patients.

Conclusions

Poorly differentiated carcinoma (WHO) and tall cell variant significantly affected patient prognosis. Poorly differentiated carcinoma (Turin) accounts only for 0.3% but showed the worst survival rates. Although poorly differentiated carcinoma (Sakamoto) predicted the likelihood of carcinoma recurrence, it is more appropriate to define this lesion as one of the histological subtypes of papillary carcinoma rather than as an independent histological entity.
Literatur
1.
Zurück zum Zitat Sobin LH, Wittekind Ch (eds) (2002) UICC: TNM classification of malignant tumors, 6th ed. Wiley-Liss, New York Sobin LH, Wittekind Ch (eds) (2002) UICC: TNM classification of malignant tumors, 6th ed. Wiley-Liss, New York
2.
Zurück zum Zitat Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura T, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; Validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848PubMedCrossRef Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura T, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma; Validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838–848PubMedCrossRef
3.
Zurück zum Zitat Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31:1196–1203CrossRef Ito Y, Hirokawa M, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2007) Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 31:1196–1203CrossRef
4.
Zurück zum Zitat Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef
5.
Zurück zum Zitat Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “Wuchernde Struma.” Am J Surg Pathol 8:655–668PubMedCrossRef Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “Wuchernde Struma.” Am J Surg Pathol 8:655–668PubMedCrossRef
6.
Zurück zum Zitat Nishiyama RH (1999) Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol 6:281–286PubMedCrossRef Nishiyama RH (1999) Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol 6:281–286PubMedCrossRef
7.
Zurück zum Zitat Rosai J (2004) Poorly differentiated thyroid carcinoima: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15:293–296PubMedCrossRef Rosai J (2004) Poorly differentiated thyroid carcinoima: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15:293–296PubMedCrossRef
8.
Zurück zum Zitat Sakamoto A (2004) Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 15:307–311PubMedCrossRef Sakamoto A (2004) Definition of poorly differentiated carcinoma of the thyroid: the Japanese experience. Endocr Pathol 15:307–311PubMedCrossRef
9.
Zurück zum Zitat Sobrinho-Simoes M (1996) Poorly differentiated thyroid carcinomas. Endocr Pathol 2:99–102CrossRef Sobrinho-Simoes M (1996) Poorly differentiated thyroid carcinomas. Endocr Pathol 2:99–102CrossRef
10.
Zurück zum Zitat Volante M, Landolfi S, Chiusa L, et al. (2004) Poorly differentiated carcinoma of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100:950–957PubMedCrossRef Volante M, Landolfi S, Chiusa L, et al. (2004) Poorly differentiated carcinoma of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100:950–957PubMedCrossRef
11.
Zurück zum Zitat Aklen LA, LiVolsi VA (2000) Poorly differentiated thyroid carcinoma – it is important. Am J Surg Pathol 24:310–313CrossRef Aklen LA, LiVolsi VA (2000) Poorly differentiated thyroid carcinoma – it is important. Am J Surg Pathol 24:310–313CrossRef
12.
Zurück zum Zitat Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205–211PubMedCrossRef Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H (1999) Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol 23:205–211PubMedCrossRef
13.
Zurück zum Zitat Wreesman V, Rhossein R (2002) Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549–1556 Wreesman V, Rhossein R (2002) Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549–1556
14.
Zurück zum Zitat Hiltizik D, Carlson DL, Tuttle RM, et al. (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. A clnicopathological study of 58 patients. Cancer 106:1286–1295CrossRef Hiltizik D, Carlson DL, Tuttle RM, et al. (2006) Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis. A clnicopathological study of 58 patients. Cancer 106:1286–1295CrossRef
15.
Zurück zum Zitat Sobrinho-Simoes M, Carcangiu ML, Albores-Saavedra J, et al. (2004) Poorly differentiated carcinoma. In: DeLeillis RA, Lloyd RV, Heitz PU, et al. (eds) Pathology and genetics of tumous of endocrine organs. IARC Press, Lyon, pp 73–76 Sobrinho-Simoes M, Carcangiu ML, Albores-Saavedra J, et al. (2004) Poorly differentiated carcinoma. In: DeLeillis RA, Lloyd RV, Heitz PU, et al. (eds) Pathology and genetics of tumous of endocrine organs. IARC Press, Lyon, pp 73–76
16.
Zurück zum Zitat Valante M, Collini P, Nikiforov EY, et al. (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorhthmic diagnostic approach. Am J Surg Pathol 31:1256–1264CrossRef Valante M, Collini P, Nikiforov EY, et al. (2007) Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorhthmic diagnostic approach. Am J Surg Pathol 31:1256–1264CrossRef
17.
Zurück zum Zitat The Japanese Society of Thyroid Surgery (2005) General rules for the description of thyroid cancer, 6th edn. Kanehara Press, Tokyo The Japanese Society of Thyroid Surgery (2005) General rules for the description of thyroid cancer, 6th edn. Kanehara Press, Tokyo
18.
Zurück zum Zitat Hawk WA, Hazard JB (1976) The many appearances of ppapillary carcinoma of the thyroid. Clevel Clin Q 43:207–215 Hawk WA, Hazard JB (1976) The many appearances of ppapillary carcinoma of the thyroid. Clevel Clin Q 43:207–215
19.
Zurück zum Zitat Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC (1988) Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 12:22–27PubMedCrossRef Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC (1988) Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol 12:22–27PubMedCrossRef
20.
Zurück zum Zitat Egea AM, Gonzales JMR, Perez JS, Cogollos TS, Paricio PP (1993) Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol 19:517–521 Egea AM, Gonzales JMR, Perez JS, Cogollos TS, Paricio PP (1993) Prognostic value of the tall cell variety of papillary cancer of the thyroid. Eur J Surg Oncol 19:517–521
21.
Zurück zum Zitat Michels JJ, Jacques M, Henry-Amar M, Bardet S (2007) Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Human Pathol 38:212–219CrossRef Michels JJ, Jacques M, Henry-Amar M, Bardet S (2007) Prevalence and prognostic significance of tall cell variant of papillary thyroid carcinoma. Human Pathol 38:212–219CrossRef
22.
Zurück zum Zitat Sanders EM, LiVolsi VA, Brierley J, et al. (2007) An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934–945PubMedCrossRef Sanders EM, LiVolsi VA, Brierley J, et al. (2007) An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934–945PubMedCrossRef
23.
Zurück zum Zitat Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–1908PubMedCrossRef Akslen LA, LiVolsi VA (2000) Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer 88:1902–1908PubMedCrossRef
Metadaten
Titel
Prevalence and Prognostic Significance of Poor Differentiation and Tall Cell Variant in Papillary Carcinoma in Japan
verfasst von
Yasuhiro Ito
Mitsuyoshi Hirokawa
Mitsuhiro Fukushima
Hiroyuki Inoue
Tomonori Yabuta
Takashi Uruno
Minoru Kihara
Takuya Higashiyama
Yuuki Takamura
Akihiro Miya
Kaoru Kobayashi
Fumio Matsuzuka
Akira Miyauchi
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9406-7

Weitere Artikel der Ausgabe 7/2008

World Journal of Surgery 7/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.